Server-side processing permits 3D image manipulation to take place on a central server before being transmitted to a thin client. This is one innovation that will help facilities meet meaningful use criteria regarding the integration of advanced visualization imaging into the EMR. But there are still some technical challenges ahead.

Researchers from the Hospital of the University of Pennsylvania have developed an automated radiation dose extraction tool that polls existing CT dose datasets to extract dose-related parameters, which may be used to train and educate healthcare providers and create cumulative radiation dose profiles for patients. The system delivers improved patient care and management, stated the authors in an article published in the November issue of the Journal of the American College of Radiology.

Stryker has entered a definitive agreement to acquire the assets of Boston Scientific's neurovascular division for $1.5 billion.

The Patient Protection and Affordable Care Act, amended by the HealthCare and Education Reconciliation Act of 2010 is a controversial and polarizing law about which reasonable and intelligent people can disagree in good faith, said Roger Vinson, senior U.S. District Judge, beginning his Oct. 14 ruling in favor of allowing 20 states to move forward with a challenge to the constitutionality of President Barack Obama's healthcare reform legislation.

The incidence of cardiovascular (CV) disease will increase by 73 percent in China by 2030, and researchers expect the CV device market to skyrocket to $1.6 billion in 2016, making it the largest of the emerging countries, according to a report published by GlobalData.

GE Healthcare has completed a digital imaging repository that connects hospitals and medical centers throughout southwestern Ontario, Canada, enabling the sharing of patient health data across the region.

As investments in IT increase at the nations healthcare organizations, CIOs will have their hands full in managing the speed of technological change.

The FDA has approved an expanded indication for three of Boston Scientific's cardiac resynchronization therapy defibrillators (CRT-Ds). Along with their use in patients with Class III and IV heart failure, the devices can now be used in high-risk patients with Class I and II heart failure with left bundle branch block.